A Galletto Pregliasco1, A Collin1, A Guéguen2, M A Metten3, J Aboab2, R Deschamps2, O Gout2, L Duron1, J C Sadik1, J Savatovsky1, A Lecler4. 1. From the Departments of Radiology (A.G.P., A.C., L.D., J.C.S., J.S., A.L.). 2. Neurology (A.G., J.A., R.D., O.G.). 3. Clinical Research Unit (M.A.M.), Fondation Ophtalmologique Adolphe de Rothschild, Paris, France. 4. From the Departments of Radiology (A.G.P., A.C., L.D., J.C.S., J.S., A.L.) alecler@for.paris.
Abstract
BACKGROUND AND PURPOSE: MR imaging is the key examination in the follow-up of patients with MS, by identification of new high-signal T2 brain lesions. However, identifying new lesions when scrolling through 2 follow-up MR images can be difficult and time-consuming. Our aim was to compare an automated coregistration-fusion reading approach with the standard approach by identifying new high-signal T2 brain lesions in patients with multiple sclerosis during follow-up MR imaging. MATERIALS AND METHODS: This prospective monocenter study included 94 patients (mean age, 38.9 years) treated for MS with dimethyl fumarate from January 2014 to August 2016. One senior neuroradiologist and 1 junior radiologist checked for new high-signal T2 brain lesions, independently analyzing blinded image datasets with automated coregistration-fusion or the standard scroll-through approach with a 3-week delay between the 2 readings. A consensus reading with a second senior neuroradiologist served as a criterion standard for analyses. A Poisson regression and logistic and γ regressions were used to compare the 2 methods. Intra- and interobserver agreement was assessed by the κ coefficient. RESULTS: There were significantly more new high-signal T2 lesions per patient detected with the coregistration-fusion method (7 versus 4, P < .001). The coregistration-fusion method detected significantly more patients with at least 1 new high-signal T2 lesion (59% versus 46%, P = .02) and was associated with significantly faster overall reading time (86 seconds faster, P < .001) and higher reader confidence (91% versus 40%, P < 1 × 10-4). Inter- and intraobserver agreement was excellent for counting new high-signal T2 lesions. CONCLUSIONS: Our study showed that an automated coregistration-fusion method was more sensitive for detecting new high-signal T2 lesions in patients with MS and reducing reading time. This method could help to improve follow-up care.
BACKGROUND AND PURPOSE: MR imaging is the key examination in the follow-up of patients with MS, by identification of new high-signal T2 brain lesions. However, identifying new lesions when scrolling through 2 follow-up MR images can be difficult and time-consuming. Our aim was to compare an automated coregistration-fusion reading approach with the standard approach by identifying new high-signal T2 brain lesions in patients with multiple sclerosis during follow-up MR imaging. MATERIALS AND METHODS: This prospective monocenter study included 94 patients (mean age, 38.9 years) treated for MS with dimethyl fumarate from January 2014 to August 2016. One senior neuroradiologist and 1 junior radiologist checked for new high-signal T2 brain lesions, independently analyzing blinded image datasets with automated coregistration-fusion or the standard scroll-through approach with a 3-week delay between the 2 readings. A consensus reading with a second senior neuroradiologist served as a criterion standard for analyses. A Poisson regression and logistic and γ regressions were used to compare the 2 methods. Intra- and interobserver agreement was assessed by the κ coefficient. RESULTS: There were significantly more new high-signal T2 lesions per patient detected with the coregistration-fusion method (7 versus 4, P < .001). The coregistration-fusion method detected significantly more patients with at least 1 new high-signal T2 lesion (59% versus 46%, P = .02) and was associated with significantly faster overall reading time (86 seconds faster, P < .001) and higher reader confidence (91% versus 40%, P < 1 × 10-4). Inter- and intraobserver agreement was excellent for counting new high-signal T2 lesions. CONCLUSIONS: Our study showed that an automated coregistration-fusion method was more sensitive for detecting new high-signal T2 lesions in patients with MS and reducing reading time. This method could help to improve follow-up care.
Authors: Frederik Barkhof; Jack H Simon; Franz Fazekas; Marco Rovaris; Ludwig Kappos; Nicola de Stefano; Chris H Polman; John Petkau; Ernst W Radue; Maria P Sormani; David K Li; Paul O'Connor; Xavier Montalban; David H Miller; Massimo Filippi Journal: Nat Rev Neurol Date: 2011-12-06 Impact factor: 42.937
Authors: I Leng Tan; Ronald A van Schijndel; Petra J W Pouwels; Herman J Adèr; Frederik Barkhof Journal: AJR Am J Roentgenol Date: 2002-09 Impact factor: 3.959
Authors: Maria Pia Sormani; Claudio Gasperini; Marzia Romeo; Jordi Rio; Massimiliano Calabrese; Eleonora Cocco; Christian Enzingher; Franz Fazekas; Massimo Filippi; Antonio Gallo; Ludwig Kappos; Maria Giovanna Marrosu; Vittorio Martinelli; Luca Prosperini; Maria Assunta Rocca; Alex Rovira; Till Sprenger; Maria Laura Stromillo; Gioacchino Tedeschi; Mar Tintorè; Carla Tortorella; Maria Trojano; Xavier Montalban; Carlo Pozzilli; Giancarlo Comi; Nicola De Stefano Journal: Neurology Date: 2016-06-15 Impact factor: 9.910
Authors: Mark A Horsfield; Maria A Rocca; Elisabetta Pagani; Loredana Storelli; Paolo Preziosa; Roberta Messina; Fabiano Camesasca; Massimiliano Copetti; Massimo Filippi Journal: J Neuroimaging Date: 2016-03-28 Impact factor: 2.486
Authors: N Patel; M A Horsfield; C Banahan; A G Thomas; M Nath; J Nath; P B Ambrosi; E M L Chung Journal: AJNR Am J Neuroradiol Date: 2017-03-31 Impact factor: 3.825
Authors: Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky Journal: Ann Neurol Date: 2011-02 Impact factor: 10.422
Authors: D Zopfs; K Laukamp; R Reimer; N Grosse Hokamp; C Kabbasch; J Borggrefe; L Pennig; A C Bunck; M Schlamann; S Lennartz Journal: AJNR Am J Neuroradiol Date: 2022-01-06 Impact factor: 3.825